期刊文献+

利福平耐药实时荧光定量核酸扩增检测技术对脊柱结核不同类型标本检测的研究 被引量:15

A retrospective study on the role of automated real - time nucleic acid amplification technology for rapid and simultaneous detection of mycobacterium tuberculosis and rifampicin resistance in testing different types of tissue specimens of spinal tuberculosis
原文传递
导出
摘要 目的比较应用利福平耐药实时荧光定量核酸扩增检测技术(XpertMTB/RIF)对脊柱结核不同类型组织标本检测的差异。方法收集在天津市海河医院骨科接受病灶清除手术治疗诊断明确的脊柱结核患者223例,收集脓液、肉芽组织及干酪样坏死组织,分别进行结核分枝杆菌培养和XpertMTB/RIF检测,计算阳性率,并以细菌培养与表型药敏试验为金标准,计算XpertMTB/RIF进行细菌和利福平耐药基因rpoB突变检测的敏感度、特异度。结果223例脊柱结核患者多标本联合XpertMTB/RIF检测阳性率高于细菌培养阳性率,差异有统计学意义[(68.61±7.35)%比较(44.39±6.51)%,P=0.000]。两种细菌检测方法中,都是脓液阳性率最高,肉芽组织其次,干酪样坏死组织最低,差异有统计学意义[细菌培养:(44.44±7.08)%比(43.86±7.44)%比(30.72±7.3l%),P=0.017;XpertMTB/RIF检测:(73.02±6.33)%比(63.74±7.21)%比(39.87±7.76%),P=0.000]。3种标本XpertMTB/RIF检测阳性率都高于细菌培养(脓液、肉芽组织:P=0.000,差异有统计学意义;干酪样坏死组织:P=0.131,差异无统计学意义)。XpertMTB/RIF检测结核杆菌的敏感度达(96.97±3.38)%,rpoB突变检测的敏感度(97.44%)和特异度(94.74%)也较高。结论脊柱结核患者应尽量获取多种标本,尤其脓液标本,进行XpertMTB/RIF检测,可简便、快速、准确地诊断结核感染及评估其耐药性,有助于开展有效治疗。 Objective To compare the role of automated real - time nucleic acid amplification technology for rapid and simultaneous detection of mycobacterium tuberculosis and rifampicin resistance (Xpert MTB/RIF) in testing different types of tissue specimens of spinal tuberculosis. Methods The pus, granulation tissue and caseous necrotic tissue of 223 patients who were diagnosed as having spinal tu- berculosis (TB) and received curettage at the Department of Orthopedics of Tianjin Haihe Hospital were collected for bacterial culture and Xpert MTB/RIF assay. Also, the bacterial culture and phenotypic drug- sensitivity test were adopted as the golden standards to calculate the sensitivity and specificity of Xpert MTB/RIF assay. Results The positive rate of Xpert MTB/RIF assays on spinal TB patients' tissue specimens was higher than that of bacterial culture [ ( 68.61± 7.35 ) % vs. ( 44. 39±6. 51 ) % , P = 0. 000 ]. The positive rate of pus was the highest, followed by granulation tissue, and the caseous necrotic tissue was the lowest by both methods with statistically significant difference [ bacterial culture: (44.44 ± 7.08)% 〉 (43.86±7.44)% 〉 (30.72±7.31%), P=0.017; Xpert MTB/RIF assay: (73.02±6. 33 ) % 〉 (63.74 ±7.21 ) % 〉 (39. 87± 7.76% ), P = 0. 000 ]. The positive rate of Xpert MTB/RIF assay was higher than that of bacterial culture in all three types of specimens ( pus and granulation tissue : P = O. 000, with statistically significant difference; caseous necrotic tissue: P = 0. 131, without statistically significant difference). The sensitivity of Xpert MTB/RIF assay on mycobacterium tuberculosis was up to (96. 97 ± 3.38) % while the sensitivity (97.44%) and specificity (94. 74% ) of drug - sensitivity test al- so remained relatively high. Conclusion For efficient and accurate diagnosis of TB and drug - resistance test and timely provision of effective treatment, multiple specimens, especially the pus of spinal TB pa- tients, should be collected for Xpert MTB/RIF assays.
作者 唐亮 冯世庆 高瑞霄 韩臣富 孙晓晨 鲍玉成 张文龙 Tang Liang;Feng Shiqing;Gao Ruixiao;Hart Chenfu;Sun Xiaochen;Bao Yucheng;Zhang Wenlong(Department of Orthopedics,Tianfin Medical University General Hospital,Tianfin 300052,China(Tang L,Feng SQ;Department of Orthopedics,Tianjin Haihe Hospital,Tianfin 300350,Chin;Department of lnternal Medicine,Tianjin Haihe Hospital,Tianjin 300350,China)
出处 《中华实验外科杂志》 CAS CSCD 北大核心 2018年第9期1764-1766,共3页 Chinese Journal of Experimental Surgery
基金 天津市卫生局科技基金(2015KZ046) 津南区科委科技计划项目(20161521)
关键词 脊柱结核 分子诊断 结核分枝杆菌 Spinal tuberculosis Molecular diagnostics Mycobacterium tuberculosis
  • 相关文献

参考文献2

二级参考文献60

  • 1Raviglione M, Marais B, Floyd K, et al. Scaling up intervenetions to achieve global tuberculosis controh progress and new developments. Lancet, 2012, 379(9829): 1902-1913.
  • 2Golden MP, Vikram HR. Extrapulmonary tuberculosis: an overview. Am Fam Physician, 2005, 72(9): 1761-1768.
  • 3Kulchavenya E. Extrapulmonary tuberculosis: are statistical reports accurate? Ther Adv Infect Dis, 2014, 2 (2) : 61-70.
  • 4Theron G, Ziienah L, Chanda D, et al. Feasibility, accuracy, and clinical effect of point-of-care Xpert MTB/RIF testing fortuberculosis in primary-care settings in Africa: a multicentre, randomised, controlled trial. Lancet, 2014, 383 (9915): 424-435.
  • 5Davis JL, Kawamura LM, Chaisson LH, et al. Impact of GeneXpert MTB/RIF on patients and tuberculosis programs in a low-burden setting, a hypothetical trial. Am J respir Crit Care med,2014, 189(12) : 1551-1559.
  • 6Blakemore R, Story E, Helb D, et al. Evaluation of the ana- lytical performance of the Xpert MTB/RIF assay. J Clin Microbiol, 2010, 48(7):2495-2501.
  • 7Helb D,Jones M,Story E, et al. Rapid detection of Mycobacte- rium tuberculosis and rifampin resistance by use of on demand, near-patient technology. J Clin Microbiol, 2010, 48 (1): 229-237.
  • 8劳海黎,周蕾.GeneXpertMTB/RIF系统在快速诊断肺结核中应用价值的研究.大家健康(下旬版),2014,8(20):345-346.
  • 9Musser JM. Antimicrobial agent resistance in mycobacteria: molecular genetic insights. Clin Microbiol Rev, 1995, 8(4): 496- 514.
  • 10Sreevatsan S,Pan X, Stockbauer KE, et al. Restricted struc- tural gene polymorphism in the Mycobacterium tuberculosis com- plex indicates evolutionarily recent global dissemination. Proc Natl Acad Sci USA, 1997,94(18) : 9869-9874.

共引文献25

同被引文献100

引证文献15

二级引证文献49

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部